510(k) Report

FDA applicant

Neurolief, Ltd.

Netanya, IL3 decisions2021–20250 recalls

FDA records 3 decisions for Neurolief, Ltd. (Netanya, IL) from 2021 to 2025: 2 510(k) clearances and 1 original PMA approval. Most are in product codes PCC (Stimulator, Nerve, Electrical, Transcutaneous…) and JXK (Cranial Electrotherapy Stimulator To Treat…). Its devices cite 2 predicates, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Neurolief, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2021: 22025: 1
2021high 2 (2021) · low 0 (2022)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2021.

FIG. 1 — Neurolief, Ltd. by year, 2021–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Neurolief, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report